(Q30430808)

English

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Adjuvant systemic therapy for breast cancer in BRCA1/BRCA2 mutation carriers in a population-based study of risk of contralateral breast cancer (English)

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

systemic therapy

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Therese Törngren

11

0 references

Marinela Capanu

17

0 references

Lisbeth Bertelsen

14

0 references

Patrick Concannon

8

0 references

object named as

Anne S Reiner

16

0 references

Leslie Bernstein

4

object named as

Leslie Bernstein

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Kathleen E. Malone

18

object named as

Kathleen E Malone

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Kerryn W Reding

1

object named as

Kerryn W Reding

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

9

object named as

Ake Borg

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Bryan M Langholz

3

object named as

Bryan M Langholz

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Jonine L Bernstein

2

object named as

Jonine L Bernstein

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Sharon N Teraoka

10

object named as

Sharon N Teraoka

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

13

object named as

Shanyan Xue

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

author name string

Robert W Haile

5

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Colin B Begg

6

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Charles F Lynch

7

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Anh Diep

12

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Xiaolin Liang

15

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

WECARE Collaborative Study Group

19

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

language of work or name

0 references

publication date

5 February 2010

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

123

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

2

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

491-498

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Variation of breast cancer risk among BRCA1/2 carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

Treatment of hereditary breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

Management updates for women with a BRCA1 or BRCA2 mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

Response to neo-adjuvant chemotherapy in women with BRCA1-positive breast cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

Clinical management of BRCA1 and BRCA2 mutation carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

BRCA1 and BRCA2: chemosensitivity, treatment outcomes and prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

The role of BRCA1 in the cellular response to chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

Study design: evaluating gene-environment interactions in the etiology of breast cancer - the WECARE study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

Repair of DNA interstrand crosslinks: molecular mechanisms and clinical relevance.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

Interpreting epidemiological research: blinded comparison of methods used to estimate the prevalence of inherited mutations in BRCA1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

Contralateral breast cancer risk is influenced by the age at onset in BRCA1-associated breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

A population-based study of contralateral breast cancer following a first primary breast cancer (Washington, United States)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

28 July 2018

Population-based study of the risk of second primary contralateral breast cancer associated with carrying a mutation in BRCA1 or BRCA2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

26 November 2018

Effect of systemic adjuvant treatment on risk for contralateral breast cancer in the Women's Environment, Cancer and Radiation Epidemiology Study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

26 November 2018

American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

26 November 2018

Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

26 November 2018

A significant response to neoadjuvant chemotherapy in BRCA1/2 related breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

26 November 2018

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2903659

26 November 2018

Ten-Year Multi-Institutional Results of Breast-Conserving Surgery and Radiotherapy inBRCA1/2-Associated Stage I/II Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135344

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence and Penetrance of BRCA1 and BRCA2 Gene Mutations in Unselected Ashkenazi Jewish Women With Breast Cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135344

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk of contralateral breast cancer: associations with factors related to initial breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135344

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk factors predicting the incidence of second primary breast cancer among women diagnosed with a first primary breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135344

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

BRCA-associated breast cancer: absence of a characteristic immunophenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135344

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status

1 reference

https://pubmed.ncbi.nlm.nih.gov/20135344

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10549-010-0769-3

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

17 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30430808&oldid=2194848411"